This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound ... or “somewhat” favor having Medicare and Medicaid cover weight-loss drugs ...

BUFFALO, N.Y. — In January, Nicole Albanese, PharmD, clinical associate professor of pharmacy practice in the University at ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine ...

Executive order on prescription drug pricing supports key drug industry efforts to weaken the Medicare negotiation program.